These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


404 related items for PubMed ID: 30967390

  • 1. Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer.
    Simmons AR, Fourkala EO, Gentry-Maharaj A, Ryan A, Sutton MN, Baggerly K, Zheng H, Lu KH, Jacobs I, Skates S, Menon U, Bast RC.
    Cancer Prev Res (Phila); 2019 Jun; 12(6):391-400. PubMed ID: 30967390
    [Abstract] [Full Text] [Related]

  • 2. LyGDI is a promising biomarker for ovarian cancer.
    Zhen H, Yang S, Wu H, Wang S, Lv J, Ma L, Zhang X.
    Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
    Shen Y, Li L.
    Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144
    [Abstract] [Full Text] [Related]

  • 5. Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study.
    Lea J, Sharma R, Yang F, Zhu H, Ward ES, Schroit AJ.
    Oncotarget; 2017 Feb 28; 8(9):14395-14407. PubMed ID: 28122335
    [Abstract] [Full Text] [Related]

  • 6. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
    Abdel-Azeez HA, Labib HA, Sharaf SM, Refai AN.
    Asian Pac J Cancer Prev; 2010 Feb 28; 11(1):111-6. PubMed ID: 20593939
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial.
    Pinsky PF, Zhu C, Skates SJ, Black A, Partridge E, Buys SS, Berg CD.
    Int J Cancer; 2013 May 01; 132(9):2127-33. PubMed ID: 23065684
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations.
    Lentz SE, Powell CB, Haque R, Armstrong MA, Anderson M, Liu Y, Jiang W, Chillemi G, Shaw S, Alvarado MM, Kushi LH, Skates SJ.
    Gynecol Oncol; 2020 Dec 01; 159(3):804-810. PubMed ID: 33012551
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
    Plotti F, Capriglione S, Terranova C, Montera R, Aloisi A, Damiani P, Muzii L, Scaletta G, Benedetti-Panici P, Angioli R.
    Tumour Biol; 2012 Dec 01; 33(6):2117-23. PubMed ID: 22875782
    [Abstract] [Full Text] [Related]

  • 14. Clinical usefulness of high levels of C-reactive protein for diagnosing epithelial ovarian cancer.
    Yang D, Li H, Sun X, Yang S, Wang K, Liu Z.
    Sci Rep; 2020 Nov 18; 10(1):20056. PubMed ID: 33208875
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum 8-OHdG is associated with poor prognosis in epithelial ovarian cancer.
    Pylväs M, Puistola U, Laatio L, Kauppila S, Karihtala P.
    Anticancer Res; 2011 Apr 18; 31(4):1411-5. PubMed ID: 21508394
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses.
    Dewan R, Dewan A, Jindal M, Bhardawaj M.
    Asian Pac J Cancer Prev; 2019 Apr 29; 20(4):1103-1108. PubMed ID: 31030480
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.